MARKET

BLACR

Bellevue Life Sciences Acquisition Rights Exp 9 Feb 2028
BLACR
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-
-
0.0623
-
Woori IO Shareholders Approve Share Exchange with OSR Holdings
Reuters · 5d ago
WOORI IO SHAREHOLDERS APPROVE SHARE EXCHANGE TO BECOME WHOLLY-OWNED SUBSIDIARY OF OSR HOLDINGS
Reuters · 5d ago
Emerging Growth Research Reaffirms Buy on OSR Holdings With $10 Price Target
Reuters · 12/04 20:19
BRIEF-OSR Holdings Says Vaximm AG Shortens Exclusivity Period With BCM Europe To Three Months
Reuters · 12/02 18:22
OSR HOLDINGS INC - VAXIMM AG SHORTENS EXCLUSIVITY PERIOD WITH BCM EUROPE TO THREE MONTHS
Reuters · 12/02 14:55
Vaximm AG Shortens Exclusivity Period With BCM Europe for Cancer Immunotherapy Deal
Reuters · 12/02 14:54
OSR Holdings to Present Corporate Overview at Emerging Growth Conference
Reuters · 12/01 20:02
Vaximm AG Enters $835M License Term Sheet With BCM Europe for Cancer Immunotherapy
Reuters · 11/25 15:56
More

Webull offers Bellevue Life Sciences Acquisition Rights Exp 9 Feb 2028 stock information, including NASDAQ: BLACR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLACR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLACR stock methods without spending real money on the virtual paper trading platform.